Reneo Pharmaceuticals
Reneo Pharmaceuticals is a clinical stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases. Many of these diseases are associated with deficiencies in mitochondrial energy production. The company's goal is to improve daily function and quality of life of patients suffering from these diseases, most specifically, by improving how their mitochondria work, preserving muscle function and preventing muscle injury, weakness and wasting. The experienced team of drug development experts, who have collaborated on many successful programs, is dedicated and passionate about finding effective therapies for these complex rare diseases.
About Reneo Pharmaceuticals
Founded
2017Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$200MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
IrvineState
CaliforniaCountry
United StatesTech Stack (73)
Programming Languages And Frameworks
Devops And Development
Platform And Storage
Customer Management
Communications
Finance And Accounting
Business Intelligence And Analytics
IT Security
Computer Networks
Productivity And Operations
Analytics and Tracking
Widgets
Cloudflare Bot Manager
Yoast Plugins
Sitelinks Search Box
Google Font API
Wordpress Plugins
Google Tag Manager
Twemoji
Contact Form 7
Elementor
GTM4WP
reCAPTCHA
Font Awesome
ElementsKit Elementor
Page Links To
US Privacy User Signal Mechanism
Azure Active Directory
Essential Addons for Elementor
CrUX Dataset
DocuSign
Premium Addons for Elementor